Medicover Ab Stock Fundamentals

Medicover AB fundamentals help investors to digest information that contributes to Medicover's financial success or failures. It also enables traders to predict the movement of Medicover Stock. The fundamental analysis module provides a way to measure Medicover's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medicover stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Medicover AB Company Return On Asset Analysis

Medicover's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Medicover Return On Asset

    
  0.0401  
Most of Medicover's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medicover AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Medicover AB has a Return On Asset of 0.0401. This is 100.46% lower than that of the Healthcare sector and 99.27% lower than that of the Health Care Plans industry. The return on asset for all Sweden stocks is 128.64% lower than that of the firm.

Medicover AB Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Medicover's current stock value. Our valuation model uses many indicators to compare Medicover value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medicover competition to find correlations between indicators driving Medicover's intrinsic value. More Info.
Medicover AB is considered to be number one stock in return on equity category among related companies. It is considered to be number one stock in return on asset category among related companies reporting about  0.52  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medicover AB is roughly  1.91 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Medicover by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Medicover's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medicover's earnings, one of the primary drivers of an investment's value.

Medicover Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medicover's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medicover could also be used in its relative valuation, which is a method of valuing Medicover by comparing valuation metrics of similar companies.
Medicover is currently under evaluation in return on asset category among related companies.

Medicover Fundamentals

About Medicover Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Medicover AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicover using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicover AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Medicover AB provides diagnostic and healthcare services in Germany, Romania, Ukraine, Poland, Belarus, Moldova, Serbia, Turkey, Georgia, Bulgaria, India, and Hungary. Medicover AB was founded in 1995 and is headquartered in Stockholm, Sweden. Medicover operates under Health Care Plans classification in Sweden and is traded on Stockholm Stock Exchange. It employs 20970 people.

Pair Trading with Medicover

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medicover position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicover will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Medicover could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medicover when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medicover - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medicover AB to buy it.
The correlation of Medicover is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medicover moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medicover AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medicover can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medicover AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Medicover Stock analysis

When running Medicover's price analysis, check to measure Medicover's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicover is operating at the current time. Most of Medicover's value examination focuses on studying past and present price action to predict the probability of Medicover's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicover's price. Additionally, you may evaluate how the addition of Medicover to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Global Correlations
Find global opportunities by holding instruments from different markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Transaction History
View history of all your transactions and understand their impact on performance
Please note, there is a significant difference between Medicover's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medicover is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medicover's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.